We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02132624
Brief Title: CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

First Submitted : May 5, 2014
First Submitted that Met QC Criteria : May 5, 2014
First Posted : May 7, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 27, 2017
Last Update Posted : October 30, 2017